India Pharma 2026: Policy Push and Innovation Fuel Pharmaceutical Industry Growth
9th India Pharma highlights policy support and innovation as key drivers of growth, with leaders emphasising biosimilars, specialty medicines and stronger industry-academia collaboration.
Biosimilars Specialty Medicines India | 14/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy